Biosimilars Market is Expected to Grow from USD 27.30 Billion 2023 to reach USD 92 Billion in 2031 | SkyQuest Technology
July 02, 2024 09:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, July 02, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the biosimilars market will attain a value of USD 92 billion by 2031, with a CAGR of 16.4% during the forecast period (2024-2031)....
Global Biosimilars Market Size to reach USD 56.40 Billion by 2030 | CAGR 22.80 %; Spherical Insights & Consulting
November 01, 2022 06:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market Size was valued at USD 17.6 Billion in 2021, the market is projected to grow USD 56.40 Billion in 2030, at a...
Global Biosimilars Market Growing to Exhibit a Noteworthy CAGR of 22.9% by 2033, Key Drivers, Growth and Opportunity Analysis - Research Nester
October 12, 2022 09:50 ET
|
Research Nester
New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Nester has published a detailed market report on ‘Global Biosimilars Market’ for the forecast period, i.e. 2023 – 2033 which includes the...
Biosimilars Market to reach a size of US$ 100.5 Bn by the end of 2032
September 27, 2022 09:30 ET
|
Persistence Market Research
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Rapid growth of the pharmaceutical realm and higher prices of existing biological drugs are likely to foster attractive growth avenues in the biosimilars...
Global Biosimilars Market Size is Projected to Gain USD 103.94 Billion, at a CAGR of 25.6% by 2022 to 2028 | Vantage Market Research
September 21, 2022 07:28 ET
|
Vantage Market Research
WASHINGTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Biosimilars Market finds that the increasing chronic diseases and rising cost effectiveness of...
Biosimilars Market worth $44.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
July 26, 2022 10:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 26, 2022 (GLOBE NEWSWIRE) -- Biosimilars Market size is projected to reach USD 44.7 billion by 2026 from USD 15.6 billion in 2021, at a CAGR of 23.5% during the forecast period of 2021...
With 21.5% CAGR, Global Biosimilars Market Size Worth USD 87.12 Billion in 2030, Growth Plus Reports
July 05, 2022 08:06 ET
|
Growth Plus Reports
Pune, July 05, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market is expected to clock US$ ~87.12 billion by 2030 due to a robust pipeline for biosimilars and increasing demand for biosimilars....
Biosimilars Market to Reach USD 103.94 Billion by 2028 - Low Priced Biosimilars to Boost the Market Demand – Vantage Market Research
February 14, 2022 03:39 ET
|
Vantage Market Research
WASHINGTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- The Global Biosimilars Market size is expected to reach USD 103.94 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 25.6% during the...
U.S. Biosimilars Market to Expand at 54.7% CAGR; Increasing Demand from the Unmet Populace to Create Growth Opportunities, says Fortune Business Insights
August 16, 2019 09:00 ET
|
Fortune Business Insights
Pune, Aug. 16, 2019 (GLOBE NEWSWIRE) -- The U.S. Biosimilars Market will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by...
Biosimilars Market Size to Reach $26.7 Billion by 2024: P&S Intelligence
April 15, 2019 02:00 ET
|
Prescient & Strategic Intelligence
NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, biosimilars market is expected to generate $26.7 billion revenue by 2024,...